Clinical trials: Long-acting Reversible Contraception
- Condition Long-acting Reversible Contraception
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Contraception, Women at Risk for Pregnancy
Evaluation of the Efficacy, Safety, and Tolerability of LevoCept
To assess the contraceptive efficacy (prevention of pregnancy) of LevoCept
- Trial name
- NCT04457076
- Testing
- LevoCept
- Where
- 27 sites in United States
- Volunteers
- 1,525 people, healthy volunteers welcome
- Sponsor
- Sebela Women's Health Inc.